Cancer: The type of vegetable that increases the risk of stomach cancer 'strong evidence'
CANCER remains a leading cause of death, despite vast resources being devoted to improving the dismal numbers. Striking a preemptive blow to cancer is the motivation behind ongoing research. According to an analysis of global research conducted by the cancer charity World Cancer Research Fund , a type of vegetable increases the risk of stomach cancer and the evidence is "strong". (Source: Daily Express - Health)
Source: Daily Express - Health - January 23, 2022 Category: Consumer Health News Source Type: news

FAPI-PET may improve diagnosis of gastric cancer
Hybrid PET/MR imaging with an experimental gallium-68-labeled fibroblast activatio...Read more on AuntMinnie.comRelated Reading: Ga-68 radiotracer outperforms F-18 FDG in lung cancer staging New tracer bests FDG for diagnosing liver cancer Sofie receives nod to start trial for PET tracer PET imaging lays foundation for new cancer therapies PET tracer shows promise for diagnosing breast cancer (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 19, 2022 Category: Radiology Source Type: news

Most common stomach cancer symptoms: When should you see a doctor?
STOMACH CANCER has many different digestive symptoms, but can easily be mistaken for other conditions - here's when you should see a doctor. (Source: Daily Express - Health)
Source: Daily Express - Health - January 16, 2022 Category: Consumer Health News Source Type: news

Cancer: The drug linked to a ‘doubled’ risk of cancer - millions prescribed in UK annually
SCIENTIFIC advancements in cancer research have made significant gains, helping millions receive curative treatment. But academics continue to stress that prevention is better than cure. One pill which is widely prescribed in the UK could increase the risk of stomach cancer twofold. (Source: Daily Express - Health)
Source: Daily Express - Health - January 16, 2022 Category: Consumer Health News Source Type: news

Stomach cancer: Two sensations to notice in the belly – 'see a GP'
CANCEROUS cells multiplying in the stomach can lead to notoriously "hard to spot" symptoms. However, once you are aware of the warning signs, you can seek medical assistance should they arise. (Source: Daily Express - Health)
Source: Daily Express - Health - January 15, 2022 Category: Consumer Health News Source Type: news

Omit Periop Chemo in Mismatch Repair Deficient Gastric Cancer Omit Periop Chemo in Mismatch Repair Deficient Gastric Cancer
Patients with mismatch repair deficient gastric cancer demonstrated better median overall survival when skipping perioperative chemotherapy, according to a preprint study.First Look (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 7, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Stomach cancer: Eight early-stage symptoms – ‘important to see your doctor’
WHILST medical attention has pivoted towards COVID-19, cancer still remains a problem with researchers looking into the disease. Treatments have improved over the years but still thousands each year lose a friend, relative or loved one to the condition. Being aware of the symptoms of a variety of cancers is useful. (Source: Daily Express - Health)
Source: Daily Express - Health - January 3, 2022 Category: Consumer Health News Source Type: news

What's the Best Treatment Modality for Resectable Stomach Cancer? What's the Best Treatment Modality for Resectable Stomach Cancer?
For resectable gastric cancer, neoadjuvant chemoradiation may be better than other treatment modalities for achieving pathologic complete response, according to a new analysis.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - December 29, 2021 Category: Surgery Tags: Hematology-Oncology News Source Type: news

AI System Improves Early Gastric Cancer Detection AI System Improves Early Gastric Cancer Detection
An artificial intelligence system was effective for real-time monitoring of endoscopic"blind spots" and improved detection of early gastric cancer during esophagogastroduodenoscopy.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - December 28, 2021 Category: Gastroenterology Tags: Gastroenterology News Source Type: news

CT Lung Cancer Screening Saved His Life, and Could Do So for More
THURSDAY, Dec. 23, 2021 -- Wolfgang Lehner always considered himself " a triple threat " when it came to cancer risk. One grandfather died of lung cancer in the 1970s. His other grandfather had his own bout with stomach cancer. And Lehner himself was... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 23, 2021 Category: General Medicine Source Type: news

Triple Therapy for HER2-Positive Gastric Cancer Shrinks Tumors Triple Therapy for HER2-Positive Gastric Cancer Shrinks Tumors
The addition of pembrolizumab (Keytruda) to trastuzumab (Herceptin) and platinum-based chemotherapy led to a significant improvement in overall response rate.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 22, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Researcher charged with illegal trades of Peninsula cancer drug maker's stock
The gastric cancer trial results were key to the company's $1.9 billion acquisition earlier this year by Amgen Inc. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 21, 2021 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news

Ovarian cancer symptoms: When your stomach pain is something serious - key signs explained
OVARIAN CANCER symptoms are often dismissed as side effects of irritable bowel syndrome and other less serious illnesses - but what are the differences to look out for? (Source: Daily Express - Health)
Source: Daily Express - Health - December 21, 2021 Category: Consumer Health News Source Type: news

FDA Approves Two New Indications for XARELTO ® (rivaroxaban) to Help Prevent and Treat Blood Clots in Pediatric Patients
RARITAN, NJ, Dec. 20, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the U.S. Food and Drug Administration (FDA) has approved two pediatric indications for XARELTO® (rivaroxaban): the treatment of venous thromboembolism (VTE, or blood clots) and reduction in the risk of recurrent VTE in patients from birth to less than 18 years after at least five days of initial parenteral (injected or intravenous) anticoagulant treatment; and thromboprophylaxis (prevention of blood clots and blood-clot related events) in children aged two years and older with congenital heart disease w...
Source: Johnson and Johnson - December 21, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Tumor-Associated Collagen Signature Helps Predict Gastric Cancer Prognosis Tumor-Associated Collagen Signature Helps Predict Gastric Cancer Prognosis
The level of tumor-associated collagen signature of gastric cancer may help predict which patients are likely to benefit from adjuvant chemotherapy, research from China suggests.Reuters Health Information (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - December 17, 2021 Category: Gastroenterology Tags: Hematology-Oncology News Source Type: news

Stomach cancer symptoms: The sign after eating signalling you have the deadly disease
STOMACH cancer is one of the least common cancers in the United Kingdom. The estimated lifetime risk according to Cancer Research UK is at least one in 76 for men born after 1960. For women the odds are even more positive with just, one in 130 for women born after 1960 likely to be diagnosed with the disease. (Source: Daily Express - Health)
Source: Daily Express - Health - December 11, 2021 Category: Consumer Health News Source Type: news

Stomach bloating: Swollen belly accompanied with unusual stools could be a sign of cancer
STOMACH bloating causes can range from a number of different factors. Eating too quickly, eating the wrong kinds of food or suffering with unknown medical issues including cancer. (Source: Daily Express - Health)
Source: Daily Express - Health - December 6, 2021 Category: Consumer Health News Source Type: news

Stomach cancer: The ‘warning’ signs when you go to the toilet - symptoms often 'dismissed'
STOMACH cancer can often go undetected. Early symptoms of stomach cancer can be like symptoms of common stomach conditions. (Source: Daily Express - Health)
Source: Daily Express - Health - December 5, 2021 Category: Consumer Health News Source Type: news

Key sign when eating that you should never ignore – it may be stomach cancer
Stomach cancer is one of the least common cancers in the United Kingdom. The estimated lifetime risk of being diagnosed with stomach cancer is at least one in seventy-six for men born after 1960, according to Cancer Research UK. Nevertheless, it is helpful to know the symptoms just in case you start to feel unwell. (Source: Daily Express - Health)
Source: Daily Express - Health - December 4, 2021 Category: Consumer Health News Source Type: news

Latest Phase 3 Data for First-in-Class TREMFYA ® (guselkumab) Demonstrates Significant and Durable Improvement in Signs and Symptoms of Active Psoriatic Arthritis while Maintaining its Safety Profile in Patients with Inadequate Response to Tumor Necrosis Factor Inhibition (TNFi-IR)
SPRING HOUSE, PENNSYLVANIA, December 3, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new TREMFYA® (guselkumab) efficacy and safety data from the Phase 3b COSMOS trial published in Annals of the Rheumatic Diseases (ARD), evaluating this selective interleukin (IL)-23 inhibitor in adults with active psoriatic arthritis (PsA) who demonstrated inadequate efficacy or intolerance to tumor necrosis factor inhibition (TNFi).1 Results showed significantly higher proportions of patients treated with TREMFYA had improvement in joint signs and symptoms and complete skin clearance versus...
Source: Johnson and Johnson - December 3, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

The popular 'nutritional' supplement that increases your risk of lung and stomach cancer
PURVEYORS of nutritional supplements promote the health benefits of taking them but you should be able to get all the nutritional nourishment you need from your diet. In fact, one popular nutritional supplement actually raises your risk of lung and stomach cancer, warns research. (Source: Daily Express - Health)
Source: Daily Express - Health - November 30, 2021 Category: Consumer Health News Source Type: news

What You Need to Know About Stomach Cancer
Title: What You Need to Know About Stomach CancerCategory: Health NewsCreated: 11/25/2021 12:00:00 AMLast Editorial Review: 11/29/2021 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - November 29, 2021 Category: Cancer & Oncology Source Type: news

Stomach bloating: The taste in your mouth that could indicate a tumour is growing
STOMACH bloating could in actual fact be a lump at the top of the stomach, indicative of cancer. The latest figures show that there are, on average, 6,453 cases of stomach cancer in the UK each year. (Source: Daily Express - Health)
Source: Daily Express - Health - November 26, 2021 Category: Consumer Health News Source Type: news

Consumer Health: What do you know about stomach cancer?
November is Stomach Cancer Awareness Month, which makes this a good time to learn more about stomach cancer. More than 26,000 people in the U.S. will be diagnosed with stomach cancer this year, and more than 11,000 people will die of the disease, according to the American Cancer Society. Stomach cancer accounts for about 1.5% of all new cancers diagnosed in the U.S. each year. Stomach cancer, also known as gastric cancer, can affect any part… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - November 24, 2021 Category: Databases & Libraries Source Type: news

Natco Pharma launches novel fixed-dose combination drug for colorectal, gastric cancer
Natco Pharma has launched a novel fixed-dose combination of Trifluridine and Tipiracil, used to treat advanced colorectal and gastric cancer, in the country. The company has launched the product under the brand name Tipanat in a pack of 20 tablets in a bottle (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 18, 2021 Category: Pharmaceuticals Source Type: news

Janssen Reports Positive Topline Week 48 Phase 2 Results for TREMFYA ® (guselkumab) in Adults With Moderately to Severely Active Crohn's Disease
SPRING HOUSE, PENNSYLVANIA, November 17, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced topline results from the Phase 2 GALAXI 1 clinical trial which showed rates of clinical remission (Crohn’s Disease Activity Index [CDAI]
Source: Johnson and Johnson - November 17, 2021 Category: Pharmaceuticals Source Type: news

300 Minutes a Week of Moderate Exercise May Help Ward Off Cancer
More than 46,000 cancers in America each year, or about 3 percent of cases, could be prevented by meeting physical activity guidelines. (Source: NYT Health)
Source: NYT Health - November 17, 2021 Category: Consumer Health News Authors: Gretchen Reynolds Tags: Exercise Bladder Cancer Colon and Colorectal Cancer Stomach Cancer Breast Cancer Smoking and Tobacco American Cancer Society Medicine & Science in Sports Exercise (Journal) Source Type: news

Expert Alert: What's new in gastric cancer treatment and research
ROCHESTER, Minn. ― November is Gastric Cancer Awareness Month. Gastric cancer, also known as stomach cancer, was the sixth most common cancer in 2020, with 1.09 million new cases, according to the World Health Organization. It was the fifth most common cause of cancer death in 2020. Gastric cancer is common in cer tain parts of the world, including South America and Asia. Gastric cancer is an abnormal growth of cells that begins in the stomach.… (Source: Mayo Clinic Minnesota News)
Source: Mayo Clinic Minnesota News - November 17, 2021 Category: Hospital Management Source Type: news

Gastric Cancer Prevalent in Hereditary Breast Cancer Patients Gastric Cancer Prevalent in Hereditary Breast Cancer Patients
The risk of occult gastric cancer is highly prevalent in hereditary lobular breast cancer (HLBC) families who harbor any type of CDH1 variant. Should they consider prophylactic total gastrectomy?Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - November 11, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Mayo Clinic Minute: Stomach cancer concerns
Stomach cancer, also called gastric cancer, is an abnormal growth of cells that begins in the stomach. It can affect several areas of the stomach, including the main stomach lining or where the esophagus meets the stomach. November is Stomach Cancer Awareness Month, and experts at Mayo Clinic say there is hope for patients with the disease as treatments continue to improve. Watch: The Mayo Clinic Minute https://youtu.be/hAexmiycYOA Journalists: Broadcast-quality video (1:20) is in the… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - November 11, 2021 Category: Databases & Libraries Source Type: news

Pathologic Lymph Node Staging of Gastric Cancer Pathologic Lymph Node Staging of Gastric Cancer
The role of sentinel lymph node biopsy and micrometastases in gastric cancer is unclear. This review presents the surgical, pathologic, and clinical issues surrounding LN biopsy in gastric cancer.American Journal of Clinical Pathology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 9, 2021 Category: Consumer Health News Tags: Pathology & Lab Medicine Journal Article Source Type: news

Mayo Clinic Q & amp;A podcast: Using the immune system to treat stomach cancer
Stomach cancer, also known as gastric cancer, can affect any part of the stomach. In most of the world, stomach cancers form in the main part of the stomach. But in the U.S., stomach cancer is more likely to affect the area where the esophagus meets the stomach. This area is called the gastroesophageal junction.  Where the cancer occurs in the stomach is one factor doctors consider when determining treatment options. Treatment usually includes surgery to… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - November 1, 2021 Category: Databases & Libraries Source Type: news

Add-On Ramucirumab Increases PFS in East Asians With Advanced Gastric Cancer Add-On Ramucirumab Increases PFS in East Asians With Advanced Gastric Cancer
Adding ramucirumab to paclitaxel as second-line therapy for advanced gastric cancer boosts progression-free survival in East Asian patients, the RAINBOW-Asia trial shows.Reuters Health Information (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - October 28, 2021 Category: Gastroenterology Tags: Hematology-Oncology News Source Type: news

Colorectal cancer: The sensation immediately after having a poo that can be a sign
COLORECTAL cancer, also known as bowel cancer, is the most common type of cancer diagnosed in the UK, according to the NHS. The majority of the symptoms affect your stomach, including a sensation immediately after having a poo. (Source: Daily Express - Health)
Source: Daily Express - Health - October 28, 2021 Category: Consumer Health News Source Type: news

New Analyses Suggest Favorable Results for STELARA ® (ustekinumab) When Used as a First-Line Therapy for Bio-Naïve Patients with Moderately to Severely Active Crohn’s Disease and Ulcerative Colitis
SPRING HOUSE, PENNSYLVANIA, October 25, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced data from two new analyses of STELARA® (ustekinumab) for the treatment of adults with moderately to severely active Crohn’s disease (CD) and ulcerative colitis (UC).1,2 In a modelled analysisa focused on treatment sequencing using data from randomized controlled trials, network meta-analysis and literature, results showed patient time spent in clinical remission or response was highest when STELARA was used as a first-line advanced therapy for bio-naïve patients with moderately t...
Source: Johnson and Johnson - October 25, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Advances in the Treatment of Gastric Cancer: 2020-2021 Advances in the Treatment of Gastric Cancer: 2020-2021
This review presents an update of recent advances in the treatment of esophageal and gastric cancers, including the use of immune checkpoint inhibitor therapy as first-line treatment.Current Opinion in Gastroenterology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 25, 2021 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Pancreatic cancer symptoms: Two signs on your skin of the 'silent killer’
PANCREATIC cancer is a type of cancer that starts in the pancreas, an organ near the stomach. It is the 10th most common cancer in the UK, accounting for three percent of all new cancer cases, according to Cancer Research UK. (Source: Daily Express - Health)
Source: Daily Express - Health - October 23, 2021 Category: Consumer Health News Source Type: news

3 Percent of U.S. Cancer Cases Attributable to Physical Inactivity
Population - attributable fraction varied from 3.9 percent for urinary bladder cancer to 16.9 percent for stomach cancer (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - October 22, 2021 Category: Cancer & Oncology Tags: Family Medicine, Gastroenterology, Gynecology, Internal Medicine, Nephrology, Oncology, Pulmonology, Urology, Journal, Source Type: news

Janssen Submits Application Seeking U.S. FDA Approval of STELARA ® (ustekinumab) for the Treatment of Pediatric Patients With Juvenile Psoriatic Arthritis
HORSHAM, PENNSYLVANIA, October 8, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) seeking expanded approval of STELARA® (ustekinumab) to treat pediatric patients ages 5 years and older with juvenile psoriatic arthritis (jPsA).The filing is supported by extrapolation of data from nine studies across both adult trials in active PsA and adult and pediatric studies in moderate to severe plaque psoriasis, totaling 3,997 patients evaluated across these closely associa...
Source: Johnson and Johnson - October 8, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

New Analysis Presented by Janssen at United European Gastroenterology Week (UEGW) Demonstrates Long-Term Safety Profile for STELARA ® (ustekinumab) in Older Patients Across Approved Indications
SPRING HOUSE, PENNSYLVANIA, October 4, 2021 – Today, the Janssen Pharmaceutical Companies of Johnson & Johnson announced a new analysis of STELARA® (ustekinumab) pooled safety data from 13 clinical studies across approved indications, showing rates of key safety events among adults 60 years and older treated with STELARA for up to five yearsa were similar to rates observed with placebo during the control phase of these trials.1,b Approved indications included adults with moderately to severely active Crohn’s disease (CD), moderately to severely active ulcerative colitis (UC), moderate to severe plaque p...
Source: Johnson and Johnson - October 4, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

' Regionalized' Care Tied to Better Survival in Tough Cancer'Regionalized' Care Tied to Better Survival in Tough Cancer
Regionalization of gastric cancer care within a large healthcare system increased care specialization and standardization, and improved patient outcomes.Medscape Medical News (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - September 30, 2021 Category: Radiology Tags: Hematology-Oncology News Source Type: news

Overall Cancer Incidence, Mortality Lower for U.S. Hispanics
But rates higher for infection - related cancers, such as liver and stomach cancers, and cervical cancer (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - September 24, 2021 Category: Cancer & Oncology Tags: Dermatology, Family Medicine, Gastroenterology, Gynecology, Infections, Internal Medicine, Nephrology, Oncology, Ophthalmology, ENT, Pulmonology, Urology, Journal, Source Type: news

Can Cannabis Help Your Gut?
When Joe Silverman developed Crohn’s disease at age 21, the symptoms started out mild. While the sight of blood in his stools initially freaked him out, what really bothered him was the frequent abdominal pain and bloating that occurred as his condition progressed to moderate and then severe. Dietary changes didn’t make a difference, so he began taking prescription oral anti-inflammatory drugs that are often used to treat certain bowel diseases, which alleviated but didn’t eliminate his discomfort. He started using prescription steroid suppositories to cope with flare-ups of the inflammatory bowel disease...
Source: TIME: Health - September 23, 2021 Category: Consumer Health News Authors: Stacey Colino Tags: Uncategorized Source Type: news

Robotic Gastrectomy for Gastric Cancer Does Not Cut Postop Infections
But overall incidence of postoperative complications significantly lower with robotic versus laparoscopic gastrectomy (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - September 22, 2021 Category: Cancer & Oncology Tags: Gastroenterology, Infections, Oncology, Surgery, Journal, Source Type: news

No Drop in Intra-Abdominal Infectious Complications With Robotic Gastrectomy No Drop in Intra-Abdominal Infectious Complications With Robotic Gastrectomy
Robotic gastrectomy failed to reduce intra-abdominal infectious complications compared with standard laparoscopic gastrectomy in a randomized clinical trial of 236 patients with gastric cancer.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - September 22, 2021 Category: Surgery Tags: General Surgery News Source Type: news

Screening and Treating H. Pylori in Those at High Risk for Gastric Cancer Appears Cost-Effective Screening and Treating H. Pylori in Those at High Risk for Gastric Cancer Appears Cost-Effective
Screening for and treating Helicobacter pylori infection in those at high risk for gastric cancer is cost effective, a new modeling study shows.Reuters Health Information (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - September 14, 2021 Category: Gastroenterology Tags: Hematology-Oncology News Source Type: news

Ramucirumab Shows Survival Benefits with Pleural Mesothelioma
Adding the drug ramucirumab to gemcitabine chemotherapy worked especially well in a recent clinical trial involving second-line treatment for patients with pleural mesothelioma. Ramucirumab, an immunotherapy drug also known by the brand name Cyramza, is a monoclonal antibody that works by targeting and restricting a protein that stimulates blood vessel growth within tumors. Impressive results in the phase II clinical trial moved the drug combination closer to filling the long-standing void for a second-line mesothelioma treatment. The Lancet Oncology recently published results of the study, which was conducted in ...
Source: Asbestos and Mesothelioma News - September 13, 2021 Category: Environmental Health Authors: Fran Mannino Source Type: news

Medial EarlySign signs deal with Roche to develop AI-enabled cancer detection tool
The new initiative will begin with a focus on gastric cancer.   (Source: mobihealthnews)
Source: mobihealthnews - September 13, 2021 Category: Information Technology Source Type: news

I Didn ’t Want to Push My Aunt to Get the Vaccine. Now I Live With Regrets
In normal times, the ICU is a dreadful place. Sickness lingers like a fog. You can feel it, sense it, even hear it—the machinery pumping, the alarms ringing, the nurses scrambling. In pandemic times, the ICU is chilling. Death lives here. Medical staff members wear green biohazard suits, face shields, latex gloves and shoe coverings. Strips of red tape—“ISOLATION,” they read—mark the windows and doors of individual rooms. Behind each is a patient who cannot breathe on their own, kept alive by a ventilation machine that is connected to an invasive tube running down their windpipe and into the l...
Source: TIME: Health - September 12, 2021 Category: Consumer Health News Authors: Ross Dellenger Tags: Uncategorized Source Type: news

New Report Details 9/11 Health Effects on FDNY Firefighters
A recent report from the Fire Department of New York World Trade Center Health Program outlines the 9/11-related health effects firefighters are dealing with 20 years later. Approximately 410,000 first responders spent the days and weeks after 9/11 inhaling toxic materials as they helped save lives from the collapse of the Twin Towers. Almost 3,000 people died on Sept. 11, 2001, but in the 20 years since, another 4,343 survivors have died due to related health effects. FDNY has felt the impact of delayed illness, as well. While 343 FDNY firefighters died on 9/11, another 254 have died since then from 9/11-related dis...
Source: Asbestos and Mesothelioma News - September 9, 2021 Category: Environmental Health Authors: Fran Mannino Source Type: news